Roche sec filings

Author: wmli

August undefined, 2024

WebRoche Holding AG ADR SEC filings breakout by MarketWatch. View the RHHBY U.S. Securities and Exchange Commission reporting information. Skip to main contentMain Menu Home Latest News... WebApr 10, 2024 · SEC Filings. Investor Menu. Date Filing Type Filing Description Download / View. 03/22/2024. 10-K. Annual report pursuant to Section 13 or 15 (d) 02/14/2024. SC 13G/A. [Amend] Statement of acquisition of beneficial ownership by individuals.

RHHBY Roche Holding AG ADR SEC Filings MarketWatch

Web14 hours ago · UBS 24476758 Roche 1203204 Swiss Re ... is providing an update on the status of the filing of its ... the Company has been granted a Management Cease Trade Order by the British Columbia Securities ... WebRoche Group sales: CHF 63.3 billion +2% Pharmaceuticals Division sales: CHF 45.6 billion +3% Diagnostics Division sales: CHF 17.7 billion +3% Core investments in research and development: CHF 14.1 billion +3% Core operating profit: CHF 22.2 billion +2% Dividend proposal: CHF 9.50 free google slides theme

Roche Holding Ltd - SEC Filings - Fintel.io

WebThese reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), … WebNasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. free google slides downloads

Latest SEC filings for Roche Holding AG (RHHBY)

mCloud Provides Update on Filing of Financial Statements

WebPartnering. Stories. Media. Investors. Careers. About Roche. About Roche. Strategy. Business. WebJan 13, 2024 · Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Roche, a global pioneer in pharmaceuticals and diagnostics, today announced a 15-year, non-exclusive collaboration agreement to broaden the adoption of distributable next-generation sequencing-based (NGS) testing in oncology. As the … free google slides templates natureWebFeb 14, 2024 · SEC Filings. 2024-02-13. SC 13G/A. US4718711033 / JASPER THERAPEUTICS INC / ROCHE FINANCE LTD - SC 13G/A Passive Investment. SC 13G/A 1 tm236317d2sc13ga.htm SC 13G/A CUSIP No. 471871 103 SCHEDULE 13G/A Page 1 of 6 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 … free google slides themes for education

"WebSEC filings represent the financial reports and statements filed with the Securities and Exchange Commission by Johnson & Johnson. You can search for filings below. In order to read our interactive data filings, you will need an XBRL viewer such as the viewer provided by the SEC here. Group Filing year - Any - Items per page 10 1 2 3 4 5 6 7 8 9 … " - Roche sec filings

Roche sec filings

Genentech Inc 10K Annual Reports & 10Q SEC Filings - Last10K.com

WebFeb 23, 2024 · Aep Texas Inc. (1721781) SEC Filing 10-K Annual Report for the fiscal year ending Saturday, December 31, 2024. Home. SEC Filings. Aep Texas Inc. 10-K Annual Report Thu Feb 23 2024. 10-K Annual Report Summary 10 … WebRHHVF SEC Filings - Roche Holding Ltd - Annual Report, Proxy Statement, Prospectus. ... SEC Filings All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor ...

Did you know?

WebSEC Filings Group3,4,5Annual FilingsCurrent ReportsMergers & AcquisitionsOtherProxy FilingsQuarterly FilingsRegistration Statements Filing year- Any -20242024202420242024202420242016201520142013201220112010200920082007200620052004200320022001200019991998 Pagination Current page 1 Page 2 Page 3 Page WebFeb 19, 2009 · SEC Filings Genentech Inc 10-K Annual Report Fri Feb 20 2009 318771 Annual Reports 10-K Annual Report February 2009 318771 Corporate News Other Events Other Events Earnings Release Other Events January 2009 Financial Exhibit Other Events Earnings Release Financial Exhibit Other Events October 2008 Event for Officers Financial …

WebJul 21, 2024 · Swiss giant Roche tops Pharmaceutical Executive’s 2024 list of the world’s biggest pharma companies, up from second place in 2024 and third in 2024. Though its best-selling drugs are soon to face biosimilar competition, Roche’s diverse portfolio has ensured that it can continue to drive future sales growth. WebAug 5, 2024 · This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, including without limitation statements regarding Syros’s clinical development plans and collaborations with respect to SY-5609, the evaluation of SY-5609 in combination with other therapies, the ability of SY ...

WebRoche WebFind the latest Investor updates & ad hoc announcements of Roche.

WebFind the latest SEC Filings data for Roche Holding AG Bearer Shares (RHHBF) at Nasdaq.com. Roche Holding AG Bearer Shares (RHHBF) SEC Filings Nasdaq Skip to …

WebRoche blue and red makes what colorWebOct 20, 2024 · Roche to receive license for HOOKIPA’s HB-700 program and option to license a second undisclosed novel arenaviral immunotherapy ... set forth in this press release constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. ... the timing of regulatory filings, the ... free google slides themes arcticWebApr 11, 2024 · A high-level overview of Roche Holding AG (RHHBY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ... SEC Filings. Type: All. free google slides themes freeWebFeb 14, 2024 · UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Amendment No. 1) Under the Securities Exchange Act of … free google slides template downloadWebNov 24, 2024 · Filing Detail. SEC Home » Search the Next-Generation EDGAR System » Company Search » Current Page; Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]: SEC Accession No. 0001744489-21-000220 Filing Date. 2024-11-24. Accepted. 2024-11-24 16:34:25. Documents. 165. Period of Report. 2024-10-02. Interactive Data. … blue and red paint splashWeb2024-03-20 - Roche Holding Ltd has filed an SC 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 29,319,010 shares of Senseonics Holdings Inc (US:SENS). This represents 16.48 percent ownership of the company. blue and red ombre backgroundWeb2024. Online Annual Report (FY2024) Annual Report 2024 (Integrated Report) Download the Main Report (Medium- to Long- Term Value Creation) [PDF 13.5MB 96Pages] Download the Activity Report (Detailed Short-Term Information) [PDF 5.4MB 72Pages] free google slides themes download